Efficacy, immunogenicity, and safety of a 9-valent human papillomavirus vaccine in Latin American girls, boys, and young women

Background: A 9-valent human papillomavirus (HPV6/11/16/18/31/33/45/52/58; 9vHPV) vaccine was developed to expand coverage of the previously developed quadrivalent (HPV6/11/16/18; qHPV) vaccine. Methods: Efficacy, immunogenicity, and safety outcomes were assessed in Latin American participants enrol...

Full description

Autores:

Tipo de recurso:

Fecha de publicación:

2018

Institución:

Universidad del Rosario

Repositorio:

Repositorio EdocUR - U. Rosario

Idioma:

eng

OAI Identifier:

oai:repository.urosario.edu.co:10336/18762

Acceso en línea:

https://doi.org/10.1016/j.pvr.2017.12.004
http://repository.urosario.edu.co/handle/10336/18762

Palabra clave:

9Vhpv
Cervical Cancer
Human Papillomavirus
Persistent Infection
Vaccine
Virus Antibody
Virus Dna
Wart Virus Vaccine
Adolescent
Adult
Adverse Event
Antibody Blood Level
Antibody Response
Article
Blood Analysis
Child
Controlled Study
Disease Association
Dizziness
Double Blind Procedure
Drug Efficacy
Drug Fatality
Drug Safety
Female
Fever
Gynecological Examination
Headache
Hispanic
Human
Human Papillomavirus Type 31
Human Papillomavirus Type 33
Human Papillomavirus Type 45
Human Papillomavirus Type 52
Human Papillomavirus Type 58
Injection Site Erythema
Injection Site Pain
Injection Site Pruritus
Injection Site Swelling
Major Clinical Study
Male
Nausea
Papillomavirus Infection
Priority Journal
Randomized Controlled Trial
Seroconversion
Treatment Outcome
Uterine Cervix Cytology
Uterine Cervix Dysplasia
Vaccination
Vaccine Immunogenicity
Vagina Disease
Vagina Smear
Vomiting
Vulva Disease
Papiloma
Neoplasias del cuello uterino
Vacuna contra papilomavirus

Rights

License

Abierto (Texto Completo)